Gide act as counsel to Erytech on USD144m Nasdaq IPO
Gide has advised Erytech Pharma, a company listed on Euronext Paris, on its initial public offering on the Nasdaq Global Select Market, through a reserved capital increase to American and European specialist investors for a total aggregate amount of USD144 million, after full exercise of the over-allotment option. Erytech is